Preimplantation genetic testing for aneuploidy (pgt-a) for patients aged ≤ 37 years: evidence-based medicine does not support its use a meta-analysis

Fertility and Sterility(2022)

Cited 0|Views19
No score
Abstract
To evaluate if patients aged ≤37 years truly benefit from using PGT-A as an add-on to increase ongoing pregnancy rate (OPR)/live birth rate (LBR) in their first IVF/ICSI cycle?
More
Translated text
Key words
aneuploidy,genetic testing,evidence-based,meta-analysis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined